Literature DB >> 22629012

Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining.

Ram Nawal Rao1, Priydarshi Ranjan, Nidhi Singla, Rakesh Pandey.   

Abstract

Inflammatory myofibroblastic tumor (IMFT) of the urinary bladder is an unusual spindle cell lesion that exhibits cytologic atypia, infiltrative growth, and mitotic activity mimicking malignant tumors, such as leiomyosarcoma, rhabdomyosarcoma, and sarcomatoid carcinoma. Recently, anaplastic lymphoma kinase (ALK) gene translocations or ALK protein expression in IMFT has been reported, especially in patients of children and young adults. This lesion has been described in numerous locations in addition to the urinary bladder. The detection of ALK protein and ALK gene rearrangements are useful in distinguishing IMFT from spindle cell malignancies in the urinary bladder.

Entities:  

Keywords:  Anaplastic lymphoma kinase-1; inflammatory myofibroblastic tumor; sarcomatoid urothelial carcinoma; urinary bladder

Year:  2012        PMID: 22629012      PMCID: PMC3355697          DOI: 10.4103/0974-7796.95567

Source DB:  PubMed          Journal:  Urol Ann        ISSN: 0974-7796


INTRODUCTION

Inflammatory myofibroblastic tumor (IMFT) of the urinary bladder is a very uncommon spindle cell tumor, which has undetermined malignant potential. We report a case of IMFT arising from urinary bladder in a young adult female and discuss its clinicoradiologic presentation, histopathologic and immunohistochemical diagnostic criteria, differential diagnosis, behavior, and management.

CASE REPORT

A 27-year-old female presented with painless hematuria, clots in urine, burning micturition, and weakness since 20 days. There was no past family history or tuberculosis. Urine cytology did not suggest a malignancy. The patient underwent cystoscopy, which revealed an anterior wall bladder growth. Abdominal computed tomography (CT) revealed blood clots.

Pathological findings

Gross feature

Transurethral resection of bladder tumor with partial cystectomy as an emergent operation was done due to perforation in bladder wall and infiltration of muscular layer. The cystectomy specimen measuring 8 × 8 × 5 cm along with multiple soft tissue bladder tumor chips measuring 4 × 2 × 2 cm. Outer surface is congested and showed a polypoidal growth in the bladder lumen measuring 6 × 5 cm [Figure 1] and grossly infiltrating the muscularis.
Figure 1

Partial cystectomy specimen with a polypoidal growth in the bladder lumen measuring 6 × 5 cm and grossly infiltrating the muscle layer

Partial cystectomy specimen with a polypoidal growth in the bladder lumen measuring 6 × 5 cm and grossly infiltrating the muscle layer Histopathologic examination revealed a normal urothelial lining epithelium with underlying spindle cell tumor composed of spindle-shaped cells accompanied by inflammatory infiltrates comprising lymphocytes and plasma cells [Figure 2] infiltrating the muscularis layer on a myxoid stroma. The spindle-shaped cells have a high n:c ratio, oval to elongated pleomorphic hyperchromatic nuclei, prominent nucleoli, and moderate amount of eosinophilic cytoplasm [Figure 3]. Frequent mitosis and areas of focal necrosis are also seen. Morphologic diagnosis of spindle cell neoplasms was given. Immunohistochemical profile was done in the case, which showed strong cytoplasmic staining in the myofibroblasts by anaplastic lymphoma kinase immunostaining [Figure 4]. These tumors also showed positivity for Vimentin, Cytokeratin, Smooth Muscle Actin (SMA), Muscle- specific actin (MSA) and negative for Cytokeratin 20, Desmin, S100, and CD117. A final confirmative diagnosis of IMFT was made. He has had neither recurrence nor metastasis for 15 months.
Figure 2

Section showing normal urothelial lining epithelium with underlying spindle cell tumor composed of oval- to spindle shaped cells admixed with lymphocytes and plasma cells on a myxoid stroma (H and E, ×400)

Figure 3

Section showing a tumor composed of spindle-shaped cells having high nucleocytoplasmic ratio, moderately pleomorphic hyperchromatic nuclei, prominent nucleoli, brisk mitosis, and moderate amount of eosinophilic cytoplasm (H and E, ×400)

Figure 4

Anaplastic lymphoma kinase immunohistopathologic studies revealed strong cytoplasmic staining of the myofibroblasts (H and E, ×400)

Section showing normal urothelial lining epithelium with underlying spindle cell tumor composed of oval- to spindle shaped cells admixed with lymphocytes and plasma cells on a myxoid stroma (H and E, ×400) Section showing a tumor composed of spindle-shaped cells having high nucleocytoplasmic ratio, moderately pleomorphic hyperchromatic nuclei, prominent nucleoli, brisk mitosis, and moderate amount of eosinophilic cytoplasm (H and E, ×400) Anaplastic lymphoma kinase immunohistopathologic studies revealed strong cytoplasmic staining of the myofibroblasts (H and E, ×400)

DISCUSSION

IMFT is a rare spindle cell neoplasm of the urinary bladder, characterized by atypical spindle cell proliferation accompanied by inflammatory cell infiltrate comprised primarily of lymphocytes and plasma cells. The first case was reported by Roth in 1980.[1] It is also known as peudosarcoma, atypical fibromyxoid tumor, atypical myofibroblastic and plasma cell granuloma.[2] IMFT may arise at any anatomical site, including lung, soft tissues, retroperitoneum, and bladder. IMFT exhibits morphologic and immunophenotypic overlap with malignant spindle cell tumors of the urinary bladder and diagnostic distinction from these tumors can be problematic.[3-8] Both epithelial and myogenic markers can be expressed in IMFT and may lead to a misdiagnosis of sarcomatoid carcinoma, leiomyosarcoma, and rhabdomyosarcoma.[7] The ALK-1 reactivity correlates with local recurrence[3] and muscle invasion.[5] Originally identified as a protein overexpressed in anaplastic large-cell lymphoma, ALK-1 has subsequently been shown to be overexpressed in a substantial proportion of IMFTs of various anatomic locations,[9] including the urinary bladder. In IMFT of the urinary bladder, positivity for ALK-1 by immunohistochemistry ranges from 33% to 89%, whereas ALK-1 protein expression in leiomyosarcoma and sarcomatoid urothelial carcinoma has not been reported, suggesting that ALK-1 immunohistochemical studies may be useful in the differentiation of IMFT from other spindle cell lesions in the urinary bladder [Table 1].[10]
Table 1

Differential diagnosis, morphological features, and “classical” immunohistochemical profile of spindle cell neoplasms of urinary bladder

Differential diagnosis, morphological features, and “classical” immunohistochemical profile of spindle cell neoplasms of urinary bladder Although necrosis is described in 30%[7] or more[6] of IMFTs, the presence of necrosis at the tumor–detrusor muscle interface in muscle-invasive cases was one criterion present in sarcoma that distinguished it from inflammatory pseudotumor. It may affect any age group, but it is more common in children and young adults with slight female preponderance (F:M ratio 3:4). The origin of IMFT is controversial, but a recent report suggests that it is neoplastic because of aggressive behavior, involvement of chromosome 2p23, and congenital clonality. Definite diagnostic criteria of IMFT are spindle cell proliferation, presence of stellate cells, lymphoplasmacytic infiltrates, and scattered mitoses in myxoid stroma. Immunohistochemical staining may demonstrate positivity for Anaplastic lymphoma kinase, Vimentin, SMA, and Cytokeratin. Anaplastic Lymphoma Kinase has been described as a good marker for IMFT. Myogenin, a potent marker for rhabdomyosarcoma, helped in exclusion of this tumors.[11] Because of its highly cellular nature and aggressive behavior, it can be confused with malignancy.[12] Initial biopsy and complete histopatholgic examination is recommended where complete resections are problematic. Whole surgical resection is performed to avoid local recurrence. The results of a preliminary study using nine vesical IMFT support these findings, with ALK-1 protein immunocytochemically identifiable in eight vesical IMFT (89%), but negative in all 11 sarcomatoid carcinoma, leiomyosarcoma, rhabdomyosarcoma, and neurofibromas examined from the bladder.[13] These above results agree with a recent earlier abstract that showed cytoplasmic ALK-1 staining in 12/16 (75%) IMFT, but not in 15 control cases, including leiomyosarcoma, stromal tumors, and carcinosarcomas.[14] Although a number of cases of rhabdomyosarcoma may show expression of ALK-1, particularly those of alveolar subtype, these lesions usually also express desmin and myogenin or myoD1, and show characteristic morphologic features that allow identification and distinction from IMFT. We concluded that IMFT of urinary bladder is a very rare but distinctive neoplasm with intermediate malignant potential. Optimal treatment when arising in the bladder is transurethral resection and excellent long-term prognosis. The detection of ALK protein expression is useful in distinguishing IMFT from spindle cell malignancies in the urinary bladder.
  13 in total

1.  Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases.

Authors:  Lara R Harik; Celine Merino; Jean-Michel Coindre; Mahul B Amin; Florence Pedeutour; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2006-07       Impact factor: 6.394

2.  Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.

Authors:  M H Cessna; H Zhou; S L Perkins; S R Tripp; L Layfield; C Daines; C M Coffin
Journal:  Am J Surg Pathol       Date:  2001-09       Impact factor: 6.394

3.  Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.

Authors:  J R Cook; L P Dehner; M H Collins; Z Ma; S W Morris; C M Coffin; D A Hill
Journal:  Am J Surg Pathol       Date:  2001-11       Impact factor: 6.394

4.  Reactive pseudosarcomatous response in urinary bladder.

Authors:  J A Roth
Journal:  Urology       Date:  1980-12       Impact factor: 2.649

Review 5.  Sarcomatoid carcinoma of the urinary bladder. A clinicopathologic analysis of 12 cases and review of the literature.

Authors:  R H Young; M R Wick; S E Mills
Journal:  Am J Clin Pathol       Date:  1988-12       Impact factor: 2.493

6.  Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis.

Authors:  Frédéric Mergan; Francis Jaubert; Frédérique Sauvat; Olivier Hartmann; Stephen Lortat-Jacob; Yann Révillon; Claire Nihoul-Fékété; Sabine Sarnacki
Journal:  J Pediatr Surg       Date:  2005-10       Impact factor: 2.545

7.  Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.

Authors:  Elizabeth A Montgomery; Dawn D Shuster; Ashlie L Burkart; Jose M Esteban; Anita Sgrignoli; Lori Elwood; David J Vaughn; Constance A Griffin; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2006-12       Impact factor: 6.394

8.  ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.

Authors:  Toyonori Tsuzuki; Cristina Magi-Galluzzi; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2004-12       Impact factor: 6.394

Review 9.  Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature.

Authors:  Alex Freeman; Nicola Geddes; Philippa Munson; Jean Joseph; Pramila Ramani; Ann Sandison; Cyril Fisher; M Connie Parkinson
Journal:  Mod Pathol       Date:  2004-07       Impact factor: 7.842

10.  Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder.

Authors:  William R Sukov; John C Cheville; Austin W Carlson; Brandon M Shearer; Eli J Piatigorsky; Karen L Grogg; Thomas J Sebo; Jason P Sinnwell; Rhett P Ketterling
Journal:  Mod Pathol       Date:  2007-03-30       Impact factor: 7.842

View more
  9 in total

1.  Laparoscopic excision of an inflammatory myofibroblastic tumour of the bladder disguised as deep infiltrating endometriosis.

Authors:  Ourania Koukoura; Zoi Alevra; Kitty Pavlakis; George Pistofidis
Journal:  BMJ Case Rep       Date:  2017-07-14

2.  Pediatric Endobronchial Inflammatory Myofibroblastic Tumor: A Case Report and Review of the Literature.

Authors:  Leilei Liu; Xianglei Kong; Xiaoqian Lu; Dianbo Cao
Journal:  Clin Pract       Date:  2016-12-07

3.  Inflammatory myofibroblastic tumor with extensive involvement of the bladder in an adolescent: a case report.

Authors:  Xin Lin Yi; Hao Yuan Lu; Yue Xian Wu; Wen Hui Li; Qing Gui Meng; Ji Weng Cheng; Yong Tang; Yu Liu; Xian Zhong Bai
Journal:  World J Surg Oncol       Date:  2013-08-19       Impact factor: 2.754

4.  An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor.

Authors:  Sanjivini V Jacob; John D Reith; Angerika Y Kojima; William D Williams; Chen Liu; Lizette Vila Duckworth
Journal:  Case Rep Pathol       Date:  2014-06-18

5.  Inflammatory myofibroblastic tumor of the urinary bladder with benign pelvic lymph node enlargement: a case report.

Authors:  Kazuaki Machioka; Yasuhide Kitagawa; Kouji Izumi; Seiko Kitamura; Hiroko Ikeda; Mikio Namiki
Journal:  Case Rep Oncol       Date:  2014-08-16

6.  Inflammatory myofibroblastic tumor of the bladder - an unexpected case coexisting with an ovarian teratoma.

Authors:  Zuzanna Dobrosz; Janusz Ryś; Piotr Paleń; Paweł Właszczuk; Marek Ciepiela
Journal:  Diagn Pathol       Date:  2014-07-15       Impact factor: 2.644

7.  Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report.

Authors:  Toshiki Etani; Taku Naiki; Takashi Nagai; Keitaro Iida; Ryosuke Ando; Aya Naiki-Ito; Noriyasu Kawai; Keiichi Tozawa; Kentaro Mizuno; Atsushi Okada; Tohru Mogami; Takahiro Yasui
Journal:  Case Rep Oncol       Date:  2016-08-17

8.  Assessment of the potential diagnostic role of anaplastic lymphoma kinase for inflammatory myofibroblastic tumours: a meta-analysis.

Authors:  Shuiqing Wu; Ran Xu; Qi Wan; Xuan Zhu; Lei Zhang; Hongyi Jiang; Xiaokun Zhao
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

9.  Inflammatory myofibroblastic tumor of the urinary bladder: A prognostically favorable spindle cell neoplasm.

Authors:  John Carlo V Laylo; Neddy L Lim; John Jeffrey V Remo
Journal:  Urol Case Rep       Date:  2020-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.